Toshinari Yamasaki

BAP1 loss defines a new class of renal cell carcinoma

Samuel Peña‐Llopis, Silvia Vega-Rubín-de-Celis, Arnold Liao et al. · Nature Genetics · 2012 · 973 citations · Full text

Prevalence of Cardiovascular Disease and Its Risk Factors in Primary Aldosteronism

Youichi Ohno, Masakatsu Sone, Nobuya Inagaki et al. · Hypertension · 2018 · 195 citations · Full text

A Validated Tumorgraft Model Reveals Activity of Dovitinib Against Renal Cell Carcinoma

Sharanya Sivanand, Samuel Peña‐Llopis, Hong Zhao et al. · Science Translational Medicine · 2012 · 191 citations · Full text

Urology, Oncology, U.s. Food +12

Incidence, features, and prognosis of immune-related adverse events involving the thyroid gland induced by nivolumab

Ichiro Yamauchi, Akihiro Yasoda, Shigemi Matsumoto et al. · PLoS ONE · 2019 · 132 citations · Full text

Interplay Between pVHL and mTORC1 Pathways in Clear-Cell Renal Cell Carcinoma

Blanka Kucejová, Samuel Peña‐Llopis, Toshinari Yamasaki et al. · Molecular Cancer Research · 2011 · 107 citations · Full text

Cancer Biology, Tumor Biology, Cell Regulation +16